Similar articles

• Outcomes in patients with unprotected left main coronary disease: comparison between drug-eluting stents and coronary artery by-pass grafting.

  Messori A, Maratea D, Fadda V, Trippoli S. Messori A, et al. Am J Cardiol. 2013 Mar 1;111(5):779-80. doi: 10.1016/j.amjcard.2012.11.007. Am J Cardiol. 2013. PMID: 23414652 No abstract available.
• Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting.

  Park DW, Kim YH, Yun SC, Song HG, Ahn JM, Oh JH, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ. Park DW, et al. J Am Coll Cardiol. 2011 May 24;57(21):2152-9. doi: 10.1016/j.jacc.2011.01.033. J Am Coll Cardiol. 2011. PMID: 21596230
• Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.

  Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ, Choo SJ, Chung CH, Lee JW, Park SW, Park SJ. Park DW, et al. J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097. J Am Coll Cardiol. 2010. PMID: 20946993
• Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: an updated meta-analysis of 4 randomized, controlled trials.

  Benedetto U, Ng C, Smith R, Raja SG; Cardiac Outcomes Meta-Analysis (COMET) Group. Benedetto U, et al. J Thorac Cardiovasc Surg. 2014 Nov;148(5):2430-2. doi: 10.1016/j.jtcvs.2014.08.028. Epub 2014 Aug 19. J Thorac Cardiovasc Surg. 2014. PMID: 25224547 Review. No abstract available.
• Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.

  Park DW, Park SJ. Park DW, et al. Circ Cardiovasc Interv. 2017 Jun;10(6):e004792. doi: 10.1161/CIRCINTERVENTIONS.117.004792. Circ Cardiovasc Interv. 2017. PMID: 28607000 Review.